Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Sagittarius Trial
- Status
- RECRUITING
- Phase
- PHASE3
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
- Status
- TERMINATED
- Phase
- N/A
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)
- Status
- WITHDRAWN
- Phase
- PHASE2
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
CARE1 Pragmatic Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada
- Status
- COMPLETED
- Phase
- N/A
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
- Status
- RECRUITING
- Phase
- PHASE3
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
- Status
- SUSPENDED
- Phase
- PHASE2
Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma
- Status
- RECRUITING
- Phase
- PHASE2